BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30615562)

  • 1. Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.
    Fuchs TA; Wojcik C; Wilding GE; Pol J; Dwyer MG; Weinstock-Guttman B; Zivadinov R; Benedict RH
    Mult Scler; 2020 Feb; 26(2):245-252. PubMed ID: 30615562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study.
    Fuchs TA; Ziccardi S; Dwyer MG; Charvet LE; Bartnik A; Campbell R; Escobar J; Hojnacki D; Kolb C; Oship D; Pol J; Shaw MT; Wojcik C; Yasin F; Weinstock-Guttman B; Zivadinov R; Benedict RHB
    Mult Scler Relat Disord; 2019 Sep; 34():103-111. PubMed ID: 31254960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symbol digit modalities test predicts decline of off-road driving ability in Japanese patients with multiple sclerosis.
    Maeta M; Mizuno M; Okubo S; Ogasawara M; Terauchi T; Suzuki M; Akasaka H; Sato Y; Ohi K; Maeda T
    Mult Scler Relat Disord; 2022 Dec; 68():104150. PubMed ID: 36055114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory.
    Patel VP; Walker LAS; Feinstein A
    Mult Scler Relat Disord; 2017 Oct; 17():184-189. PubMed ID: 29055455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: A 5-year longitudinal study.
    Al-Iedani O; Lea S; Alshehri A; Maltby VE; Saugbjerg B; Ramadan S; Lea R; Lechner-Scott J
    Mult Scler Relat Disord; 2024 Jan; 81():105379. PubMed ID: 38103511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Are the Minimal Detectable Changes in SDMT and Verbal Fluency Tests for Assessing Changes in Cognitive Performance in Persons with Multiple Sclerosis and Non-Multiple Sclerosis Controls?
    Magnin E; Sagawa Y; Moulin T; Decavel P
    Eur Neurol; 2020; 83(3):263-270. PubMed ID: 32634812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing Multiple Screener: An unsupervised digital screening tool for cognitive deficits in MS.
    van Dongen L; Westerik B; van der Hiele K; Visser LH; Schoonheim MM; Douw L; Twisk JWR; de Jong BA; Geurts JJG; Hulst HE
    Mult Scler Relat Disord; 2020 Feb; 38():101479. PubMed ID: 31760365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients.
    Benedict RH; Morrow SA; Weinstock Guttman B; Cookfair D; Schretlen DJ
    J Int Neuropsychol Soc; 2010 Sep; 16(5):829-35. PubMed ID: 20609273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.
    Fenu G; Fronza M; Lorefice L; Arru M; Coghe G; Frau J; Marrosu MG; Cocco E
    BMC Neurol; 2018 Dec; 18(1):212. PubMed ID: 30567519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Burggraaff J; Knol DL; Uitdehaag BMJ
    Eur Neurol; 2017; 77(5-6):246-252. PubMed ID: 28319952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting isolated cognitive relapses in persons with MS.
    Morrow SA; Weinstock ZL; Mirmosayyeb O; Conway D; Fuchs T; Jaworski MG; Eckert S; Hojnacki DH; Dwyer MG; Zivadinov R; Weinstock-Guttman B; Benedict RHB
    Mult Scler; 2023 Dec; 29(14):1786-1794. PubMed ID: 37776097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab.
    Roar M; Illes Z; Sejbaek T
    Mult Scler Relat Disord; 2016 Nov; 10():116-122. PubMed ID: 27919477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients.
    Barro C; Healy BC; Saxena S; Glanz BI; Paul A; Polgar-Turcsanyi M; Guttmann CR; Bakshi R; Weiner HL; Chitnis T
    Mult Scler; 2023 Feb; 29(2):206-211. PubMed ID: 36448331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instruments measuring change in cognitive function in multiple sclerosis: A systematic review.
    Ezegbe C; Zarghami A; van der Mei I; Alty J; Honan C; Taylor B
    Brain Behav; 2023 Jun; 13(6):e3009. PubMed ID: 37062948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.
    Filser M; Schreiber H; Pöttgen J; Ullrich S; Lang M; Penner IK
    J Neurol; 2018 Nov; 265(11):2587-2593. PubMed ID: 30171410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline.
    Wallach AI; Waltz M; Casper TC; Aaen G; Belman A; Benson L; Chitnis T; Gorman M; Graves J; Harris Y; Lotze TE; Mar S; Moodley M; Ness JM; Rensel M; Rodriguez M; Rose JW; Schreiner T; Tillema JM; Waubant E; Weinstock-Guttman B; Charvet LE; Krupp LB
    Mult Scler; 2020 Dec; 26(14):1938-1947. PubMed ID: 31775571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.